EFTA00662732Set 9
2014-05-082p680w
From: Alice Jacobs Nesselrodt
To: Alice Jacobs Nesselrodt
Subject: IMDx achieves 4th FDA clearance--QIAGEN anus C difficile QS-RGQ MDx--a test for a
serious healthcare-associated infection
Date ... exciting news (see below) to share as
IMDx achieves its first FDA clearance for QIAGEN — the QIAGEN artus C. difficile QS-RGQ MDx Kit. This is the fourth FDA
clearance ... clearances were obtained for Abbott kits). In April, the FDA cleared the
QIAGEN artus C. difficile QS-RGQ MDx Kit, developed and manufactured by IMDx, for use on the QIAGEN
https://www.justice.gov/epstein/files/DataSet%209/EFTA00662732.pdf
Clears QIAGEN's anus C. difficile QS-RGQ MDx Kit, developed in partnership with IMDx;
IMDx and QIAGEN Continue to Expand Pipeline for QlAsymphony SP/AS and Rotor-Gene Q
Instruments ... Waltham, MA — In April 2014, the FDA cleared the QIAGEN anus C. difficile QS-RGQ MDx Kit,
developed and manufactured IMDx, for use on the QIAGEN QlAsymphony RGQ MDx System ... acquired infection test menu
designed, developed and manufactured by IMDx for use on the QIAGEN QlAsymphony RGQ
MDx System, was CE-marked in March 2014. The artus VanR
https://www.justice.gov/epstein/files/DataSet%209/EFTA00605649.pdf
EFTA02519480Set 11
2013-10-167p1,049w
Physcient, Inc. •
PKA SoftTouch Corp
Porex Corporation
PowerVision Inc.
Preventice, Inc.
Pro-Lab Diagnostics
Qiagen Sciences
Quidel Corporation
Rapid Pathogen Screening, Inc.
Regenesis Biomedical, Inc.
Response Biomedical Corporation
ReVision Optics
https://www.justice.gov/epstein/files/DataSet%2011/EFTA02519480.pdf